Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 14Other hematologic neoplasm 11Myeloid 7Classical hematology 3Plasma cell 2Other neoplasm 2Dermatologic 2Sarcoma 1Genitourinary 1

Conditions

Wilms Tumor 2Testicular Neoplasms 2Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma 2Neuroblastoma 2Medulloblastoma 2Kidney Neoplasms 2Brain Neoplasms 2Astrocytoma 2Teratoma 1Retinoblastoma 1Prostatic Neoplasms 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors 1Neoplasms, Plasma Cell 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma 1Liver Neoplasms 1Leukemia 1Hepatoblastoma 1Glioma 1Familial ependymoma 1Ependymoma 1Desmoplastic Small Round Cell Tumor 1Chordoma 1

Interventions

Cyclophosphamide 8pembrolizumab 6Filgrastim 5Busulfan 5fludarabine phosphate 4fludarabine 4Nivolumab 4Flow Cytometry 4Antilymphocyte Serum 4Alemtuzumab 4Tacrolimus 3Stem Cell Transplantation 3Sirolimus 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Paclitaxel 3Mycophenolic Acid 3Melphalan 3Dexamethasone 3Carboplatin 3Biopsy 3Azacitidine 3valspodar 2atezolizumab 2aldesleukin 2X-Rays 2Vorinostat 2Vincristine 2Thiotepa 2Psychiatric Rehabilitation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma × Bone Marrow Transplantation × Genitourinary × Clear all
NCT00303719 2020-05-12

Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
342 enrolled 14 charts
GenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Kidney Neoplasms, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡